Pfizer Unexpectedly Ends Cholesterol Drug Trial

Pfizer reported third-quarter earnings that fell short of analysts' expectations while ending development of an experimental cholesterol drug. Bloomberg Intelligence's Sam Fazeli reports on "Bloomberg Daybreak: Americas." (Source: Bloomberg)

Fortescue CEO Power Says Iron Ore to Remain Core Business
30:23 - Fortescue Metals Group CEO Nev Power discusses his outlook for iron ore and talks about the company's earnings and performance. He speaks on "Bloomberg Markets." (Source: Bloomberg)
  • Surging Baht May Hurt Business
  • Fortescue Reports Full-Year Profit More Than Doubles
  • Full Show: What'd You Miss? (08/18)